Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers:
Gespeichert in:
| Beteiligte Personen: | , , , , , , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | Englisch |
| Veröffentlicht: |
Erlangen ; Nürnberg
Friedrich-Alexander-Universität Erlangen-Nürnberg
2022
|
| Schlagwörter: | |
| Links: | https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-181200 https://d-nb.info/1250006589/34 https://open.fau.de/handle/openfau/18120 |
| Umfang: | 1 Online-Ressource |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV048206563 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 220510s2022 gw o|||| 00||| eng d | ||
| 015 | |a 22,O02 |2 dnb | ||
| 016 | 7 | |a 1250006589 |2 DE-101 | |
| 024 | 7 | |a urn:nbn:de:bvb:29-opus4-181200 |2 urn | |
| 035 | |a (OCoLC)1317692198 | ||
| 035 | |a (DE-599)DNB1250006589 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |8 3\p |a eng | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-29 | ||
| 084 | |8 2\p |a 610 |2 23sdnb | ||
| 084 | |8 1\p |a 615.7 |2 23ksdnb | ||
| 100 | 1 | |a Gessner, Arne |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers |c Arne Gessner, Anna Gemeinhardt, Agnes Bosch, Dennis Kannenkeril, Christian Staerk, Andreas Mayr, Martin F. Fromm, Roland E. Schmieder, Renke Maas |
| 264 | 1 | |a Erlangen ; Nürnberg |b Friedrich-Alexander-Universität Erlangen-Nürnberg |c 2022 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |5 DE-101 |2 pdager | |
| 653 | |a SGLT-2 inhibitor | ||
| 653 | |a Empagliflozin | ||
| 653 | |a Dapagliflozin | ||
| 653 | |a Type 2 diabetes mellitus | ||
| 653 | |a Homoarginine | ||
| 653 | |a ADMA | ||
| 653 | |a SDMA | ||
| 653 | |a Cardiovascular disease | ||
| 700 | 1 | |a Gemeinhardt, Anna |e Verfasser |4 aut | |
| 700 | 1 | |a Bosch, Agnes |e Verfasser |4 aut | |
| 700 | 1 | |a Kannenkeril, Dennis |e Verfasser |4 aut | |
| 700 | 1 | |a Staerk, Christian |e Verfasser |4 aut | |
| 700 | 1 | |a Mayr, Andreas |e Verfasser |4 aut | |
| 700 | 1 | |a Fromm, Martin F. |e Verfasser |4 aut | |
| 700 | 1 | |a Schmieder, Roland E. |e Verfasser |4 aut | |
| 700 | 1 | |a Maas, Renke |e Verfasser |4 aut | |
| 787 | 0 | 8 | |i Sonderdruck aus |t Cardiovascular Diabetology |g 21 (2022), 4 |o 10.1186/s12933-021-01436-x |
| 856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-181200 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://d-nb.info/1250006589/34 |x Langzeitarchivierung Nationalbibliothek |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |q application/pdf |u https://open.fau.de/handle/openfau/18120 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 883 | 0 | |8 1\p |a aepkn |c 0,81171 |d 20220122 |q DE-101 |u https://d-nb.info/provenance/plan#aepkn | |
| 883 | 0 | |8 2\p |a aepsg |c 0,98822 |d 20220122 |q DE-101 |u https://d-nb.info/provenance/plan#aepsg | |
| 883 | 1 | |8 3\p |a npi |d 20220121 |q DE-101 |u https://d-nb.info/provenance/plan#npi | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-033587444 | |
Datensatz im Suchindex
| _version_ | 1818989435283308544 |
|---|---|
| any_adam_object | |
| author | Gessner, Arne Gemeinhardt, Anna Bosch, Agnes Kannenkeril, Dennis Staerk, Christian Mayr, Andreas Fromm, Martin F. Schmieder, Roland E. Maas, Renke |
| author_facet | Gessner, Arne Gemeinhardt, Anna Bosch, Agnes Kannenkeril, Dennis Staerk, Christian Mayr, Andreas Fromm, Martin F. Schmieder, Roland E. Maas, Renke |
| author_role | aut aut aut aut aut aut aut aut aut |
| author_sort | Gessner, Arne |
| author_variant | a g ag a g ag a b ab d k dk c s cs a m am m f f mf mff r e s re res r m rm |
| building | Verbundindex |
| bvnumber | BV048206563 |
| collection | ebook |
| ctrlnum | (OCoLC)1317692198 (DE-599)DNB1250006589 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02565nam a2200613zc 4500</leader><controlfield tag="001">BV048206563</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">220510s2022 gw o|||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">22,O02</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1250006589</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-181200</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1317692198</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1250006589</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">2\p</subfield><subfield code="a">610</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">615.7</subfield><subfield code="2">23ksdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gessner, Arne</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers</subfield><subfield code="c">Arne Gessner, Anna Gemeinhardt, Agnes Bosch, Dennis Kannenkeril, Christian Staerk, Andreas Mayr, Martin F. Fromm, Roland E. Schmieder, Renke Maas</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen ; Nürnberg</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="583" ind1="1" ind2=" "><subfield code="a">Archivierung/Langzeitarchivierung gewährleistet</subfield><subfield code="5">DE-101</subfield><subfield code="2">pdager</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SGLT-2 inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Empagliflozin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Dapagliflozin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Type 2 diabetes mellitus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Homoarginine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ADMA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SDMA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Cardiovascular disease</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gemeinhardt, Anna</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bosch, Agnes</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kannenkeril, Dennis</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Staerk, Christian</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mayr, Andreas</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fromm, Martin F.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schmieder, Roland E.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maas, Renke</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="787" ind1="0" ind2="8"><subfield code="i">Sonderdruck aus</subfield><subfield code="t">Cardiovascular Diabetology</subfield><subfield code="g">21 (2022), 4</subfield><subfield code="o">10.1186/s12933-021-01436-x</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-181200</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://d-nb.info/1250006589/34</subfield><subfield code="x">Langzeitarchivierung Nationalbibliothek</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="q">application/pdf</subfield><subfield code="u">https://open.fau.de/handle/openfau/18120</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">aepkn</subfield><subfield code="c">0,81171</subfield><subfield code="d">20220122</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepkn</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">aepsg</subfield><subfield code="c">0,98822</subfield><subfield code="d">20220122</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepsg</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">npi</subfield><subfield code="d">20220121</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#npi</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033587444</subfield></datafield></record></collection> |
| id | DE-604.BV048206563 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-20T19:38:26Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033587444 |
| oclc_num | 1317692198 |
| open_access_boolean | 1 |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | 1 Online-Ressource |
| psigel | ebook |
| publishDate | 2022 |
| publishDateSearch | 2022 |
| publishDateSort | 2022 |
| publisher | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| record_format | marc |
| spelling | Gessner, Arne Verfasser aut Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers Arne Gessner, Anna Gemeinhardt, Agnes Bosch, Dennis Kannenkeril, Christian Staerk, Andreas Mayr, Martin F. Fromm, Roland E. Schmieder, Renke Maas Erlangen ; Nürnberg Friedrich-Alexander-Universität Erlangen-Nürnberg 2022 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Archivierung/Langzeitarchivierung gewährleistet DE-101 pdager SGLT-2 inhibitor Empagliflozin Dapagliflozin Type 2 diabetes mellitus Homoarginine ADMA SDMA Cardiovascular disease Gemeinhardt, Anna Verfasser aut Bosch, Agnes Verfasser aut Kannenkeril, Dennis Verfasser aut Staerk, Christian Verfasser aut Mayr, Andreas Verfasser aut Fromm, Martin F. Verfasser aut Schmieder, Roland E. Verfasser aut Maas, Renke Verfasser aut Sonderdruck aus Cardiovascular Diabetology 21 (2022), 4 10.1186/s12933-021-01436-x https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-181200 Resolving-System kostenfrei Volltext https://d-nb.info/1250006589/34 Langzeitarchivierung Nationalbibliothek kostenfrei Volltext application/pdf https://open.fau.de/handle/openfau/18120 Verlag kostenfrei Volltext 1\p aepkn 0,81171 20220122 DE-101 https://d-nb.info/provenance/plan#aepkn 2\p aepsg 0,98822 20220122 DE-101 https://d-nb.info/provenance/plan#aepsg 3\p npi 20220121 DE-101 https://d-nb.info/provenance/plan#npi |
| spellingShingle | Gessner, Arne Gemeinhardt, Anna Bosch, Agnes Kannenkeril, Dennis Staerk, Christian Mayr, Andreas Fromm, Martin F. Schmieder, Roland E. Maas, Renke Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers |
| title | Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers |
| title_auth | Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers |
| title_exact_search | Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers |
| title_full | Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers Arne Gessner, Anna Gemeinhardt, Agnes Bosch, Dennis Kannenkeril, Christian Staerk, Andreas Mayr, Martin F. Fromm, Roland E. Schmieder, Renke Maas |
| title_fullStr | Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers Arne Gessner, Anna Gemeinhardt, Agnes Bosch, Dennis Kannenkeril, Christian Staerk, Andreas Mayr, Martin F. Fromm, Roland E. Schmieder, Renke Maas |
| title_full_unstemmed | Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers Arne Gessner, Anna Gemeinhardt, Agnes Bosch, Dennis Kannenkeril, Christian Staerk, Andreas Mayr, Martin F. Fromm, Roland E. Schmieder, Renke Maas |
| title_short | Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers |
| title_sort | effects of treatment with sglt 2 inhibitors on arginine related cardiovascular and renal biomarkers |
| url | https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-181200 https://d-nb.info/1250006589/34 https://open.fau.de/handle/openfau/18120 |
| work_keys_str_mv | AT gessnerarne effectsoftreatmentwithsglt2inhibitorsonargininerelatedcardiovascularandrenalbiomarkers AT gemeinhardtanna effectsoftreatmentwithsglt2inhibitorsonargininerelatedcardiovascularandrenalbiomarkers AT boschagnes effectsoftreatmentwithsglt2inhibitorsonargininerelatedcardiovascularandrenalbiomarkers AT kannenkerildennis effectsoftreatmentwithsglt2inhibitorsonargininerelatedcardiovascularandrenalbiomarkers AT staerkchristian effectsoftreatmentwithsglt2inhibitorsonargininerelatedcardiovascularandrenalbiomarkers AT mayrandreas effectsoftreatmentwithsglt2inhibitorsonargininerelatedcardiovascularandrenalbiomarkers AT frommmartinf effectsoftreatmentwithsglt2inhibitorsonargininerelatedcardiovascularandrenalbiomarkers AT schmiederrolande effectsoftreatmentwithsglt2inhibitorsonargininerelatedcardiovascularandrenalbiomarkers AT maasrenke effectsoftreatmentwithsglt2inhibitorsonargininerelatedcardiovascularandrenalbiomarkers |